Janux Therapeutics, Inc. (JANX)
15.20
-0.16
(-1.04%)
USD |
NASDAQ |
Dec 12, 11:58
Janux Therapeutics Free Cash Flow: -71.40M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Stoke Therapeutics, Inc. | 52.37M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Editas Medicine, Inc. | -180.70M |
| Syndax Pharmaceuticals, Inc. | -311.01M |
| Entrada Therapeutics, Inc. | -129.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.86M |
| Cash from Investing (Quarterly) | 8.306M |
| Cash from Financing (Quarterly) | 0.493M |
| Free Cash Flow Per Share (Quarterly) | -0.2088 |
| Free Cash Flow to Equity (Quarterly) | -13.42M |
| Free Cash Flow to Firm (Quarterly) | -12.95M |
| Free Cash Flow Yield | -7.75% |